nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—ABCB1—lung cancer	0.158	1	CbGaD
Trimipramine—CYP2C19—Gefitinib—lung cancer	0.03	0.0588	CbGbCtD
Trimipramine—CYP2C19—Teniposide—lung cancer	0.0291	0.057	CbGbCtD
Trimipramine—ABCB1—Topotecan—lung cancer	0.0265	0.0519	CbGbCtD
Trimipramine—CYP2C9—Gefitinib—lung cancer	0.025	0.0489	CbGbCtD
Trimipramine—ABCB1—Gefitinib—lung cancer	0.0242	0.0474	CbGbCtD
Trimipramine—CYP2C9—Teniposide—lung cancer	0.0242	0.0474	CbGbCtD
Trimipramine—CYP2D6—Gefitinib—lung cancer	0.0228	0.0447	CbGbCtD
Trimipramine—ABCB1—Vinorelbine—lung cancer	0.0187	0.0365	CbGbCtD
Trimipramine—CYP2D6—Vinorelbine—lung cancer	0.0176	0.0344	CbGbCtD
Trimipramine—CYP3A4—Topotecan—lung cancer	0.0159	0.0311	CbGbCtD
Trimipramine—ABCB1—Crizotinib—lung cancer	0.0149	0.0291	CbGbCtD
Trimipramine—CYP3A4—Gefitinib—lung cancer	0.0145	0.0284	CbGbCtD
Trimipramine—ABCB1—Gemcitabine—lung cancer	0.0145	0.0284	CbGbCtD
Trimipramine—ABCB1—Erlotinib—lung cancer	0.0143	0.028	CbGbCtD
Trimipramine—CYP3A4—Teniposide—lung cancer	0.0141	0.0276	CbGbCtD
Trimipramine—CYP2C9—Paclitaxel—lung cancer	0.0135	0.0265	CbGbCtD
Trimipramine—CYP2D6—Erlotinib—lung cancer	0.0135	0.0264	CbGbCtD
Trimipramine—ABCB1—Paclitaxel—lung cancer	0.0131	0.0257	CbGbCtD
Trimipramine—ABCB1—Irinotecan—lung cancer	0.0129	0.0253	CbGbCtD
Trimipramine—ABCB1—Vinblastine—lung cancer	0.0115	0.0225	CbGbCtD
Trimipramine—CYP3A4—Vinorelbine—lung cancer	0.0112	0.0219	CbGbCtD
Trimipramine—CYP2C9—Cisplatin—lung cancer	0.0109	0.0213	CbGbCtD
Trimipramine—CYP2D6—Vinblastine—lung cancer	0.0108	0.0212	CbGbCtD
Trimipramine—ABCB1—Cisplatin—lung cancer	0.0105	0.0206	CbGbCtD
Trimipramine—ABCB1—Etoposide—lung cancer	0.0104	0.0203	CbGbCtD
Trimipramine—ABCB1—Docetaxel—lung cancer	0.00948	0.0186	CbGbCtD
Trimipramine—CYP3A4—Crizotinib—lung cancer	0.0089	0.0174	CbGbCtD
Trimipramine—CYP3A4—Erlotinib—lung cancer	0.00859	0.0168	CbGbCtD
Trimipramine—CYP3A4—Paclitaxel—lung cancer	0.00786	0.0154	CbGbCtD
Trimipramine—CYP3A4—Irinotecan—lung cancer	0.00775	0.0152	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—lung cancer	0.00707	0.0138	CbGbCtD
Trimipramine—CYP3A4—Vinblastine—lung cancer	0.00689	0.0135	CbGbCtD
Trimipramine—ABCB1—Methotrexate—lung cancer	0.00685	0.0134	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—lung cancer	0.00666	0.013	CbGbCtD
Trimipramine—HTR2A—phrenic nerve—lung cancer	0.00658	0.301	CbGeAlD
Trimipramine—CYP3A4—Etoposide—lung cancer	0.00621	0.0122	CbGbCtD
Trimipramine—CYP3A4—Docetaxel—lung cancer	0.00568	0.0111	CbGbCtD
Trimipramine—CYP3A4—Doxorubicin—lung cancer	0.00424	0.00829	CbGbCtD
Trimipramine—HTR2A—pulmonary artery—lung cancer	0.00239	0.109	CbGeAlD
Trimipramine—HTR3A—respiratory system—lung cancer	0.000996	0.0456	CbGeAlD
Trimipramine—SLC6A3—respiratory system—lung cancer	0.000828	0.0379	CbGeAlD
Trimipramine—SLC6A4—respiratory system—lung cancer	0.000759	0.0348	CbGeAlD
Trimipramine—CYP2C9—mammary gland—lung cancer	0.000732	0.0335	CbGeAlD
Trimipramine—SLC6A2—respiratory system—lung cancer	0.000668	0.0306	CbGeAlD
Trimipramine—DRD2—respiratory system—lung cancer	0.000609	0.0279	CbGeAlD
Trimipramine—HTR3A—lung—lung cancer	0.000529	0.0242	CbGeAlD
Trimipramine—ADRA1A—epithelium—lung cancer	0.000519	0.0238	CbGeAlD
Trimipramine—HRH1—respiratory system—lung cancer	0.000481	0.022	CbGeAlD
Trimipramine—SLC6A3—lung—lung cancer	0.00044	0.0201	CbGeAlD
Trimipramine—SLC6A4—lung—lung cancer	0.000403	0.0185	CbGeAlD
Trimipramine—HRH1—epithelium—lung cancer	0.000402	0.0184	CbGeAlD
Trimipramine—HTR2A—respiratory system—lung cancer	0.000402	0.0184	CbGeAlD
Trimipramine—ADRA2A—bronchus—lung cancer	0.000389	0.0178	CbGeAlD
Trimipramine—HRH1—trachea—lung cancer	0.000355	0.0163	CbGeAlD
Trimipramine—SLC6A2—lung—lung cancer	0.000355	0.0162	CbGeAlD
Trimipramine—ADRA2A—trachea—lung cancer	0.000349	0.016	CbGeAlD
Trimipramine—HTR2A—epithelium—lung cancer	0.000336	0.0154	CbGeAlD
Trimipramine—ADRA2A—cardiac atrium—lung cancer	0.000328	0.015	CbGeAlD
Trimipramine—DRD2—lung—lung cancer	0.000323	0.0148	CbGeAlD
Trimipramine—Clomipramine—GSTP1—lung cancer	0.000303	0.113	CrCbGaD
Trimipramine—HTR2A—trachea—lung cancer	0.000297	0.0136	CbGeAlD
Trimipramine—ABCB1—respiratory system—lung cancer	0.000263	0.0121	CbGeAlD
Trimipramine—HRH1—lung—lung cancer	0.000255	0.0117	CbGeAlD
Trimipramine—ADRA2A—lung—lung cancer	0.000251	0.0115	CbGeAlD
Trimipramine—SLC6A2—lymph node—lung cancer	0.000243	0.0111	CbGeAlD
Trimipramine—ABCB1—epithelium—lung cancer	0.00022	0.0101	CbGeAlD
Trimipramine—Insomnia—Irinotecan—lung cancer	0.000218	0.00119	CcSEcCtD
Trimipramine—Flushing—Docetaxel—lung cancer	0.000218	0.00119	CcSEcCtD
Trimipramine—Vomiting—Topotecan—lung cancer	0.000217	0.00119	CcSEcCtD
Trimipramine—Malaise—Paclitaxel—lung cancer	0.000217	0.00119	CcSEcCtD
Trimipramine—Paraesthesia—Irinotecan—lung cancer	0.000216	0.00118	CcSEcCtD
Trimipramine—Cerebrovascular accident—Doxorubicin—lung cancer	0.000216	0.00118	CcSEcCtD
Trimipramine—Rash—Topotecan—lung cancer	0.000215	0.00118	CcSEcCtD
Trimipramine—Dermatitis—Topotecan—lung cancer	0.000215	0.00118	CcSEcCtD
Trimipramine—Vomiting—Erlotinib—lung cancer	0.000215	0.00118	CcSEcCtD
Trimipramine—Somnolence—Irinotecan—lung cancer	0.000214	0.00117	CcSEcCtD
Trimipramine—Thrombocytopenia—Cisplatin—lung cancer	0.000214	0.00117	CcSEcCtD
Trimipramine—Headache—Topotecan—lung cancer	0.000214	0.00117	CcSEcCtD
Trimipramine—Tachycardia—Cisplatin—lung cancer	0.000213	0.00117	CcSEcCtD
Trimipramine—HTR2A—lung—lung cancer	0.000213	0.00977	CbGeAlD
Trimipramine—Rash—Erlotinib—lung cancer	0.000213	0.00117	CcSEcCtD
Trimipramine—Dermatitis—Erlotinib—lung cancer	0.000213	0.00117	CcSEcCtD
Trimipramine—Palpitations—Paclitaxel—lung cancer	0.000213	0.00117	CcSEcCtD
Trimipramine—Convulsion—Etoposide—lung cancer	0.000213	0.00116	CcSEcCtD
Trimipramine—Insomnia—Gemcitabine—lung cancer	0.000212	0.00116	CcSEcCtD
Trimipramine—Dyspepsia—Irinotecan—lung cancer	0.000212	0.00116	CcSEcCtD
Trimipramine—Hypertension—Etoposide—lung cancer	0.000212	0.00116	CcSEcCtD
Trimipramine—Headache—Erlotinib—lung cancer	0.000212	0.00116	CcSEcCtD
Trimipramine—Paraesthesia—Gemcitabine—lung cancer	0.000211	0.00115	CcSEcCtD
Trimipramine—Asthenia—Vinorelbine—lung cancer	0.00021	0.00115	CcSEcCtD
Trimipramine—Decreased appetite—Irinotecan—lung cancer	0.000209	0.00115	CcSEcCtD
Trimipramine—Arrhythmia—Docetaxel—lung cancer	0.000209	0.00115	CcSEcCtD
Trimipramine—Eosinophilia—Methotrexate—lung cancer	0.000209	0.00114	CcSEcCtD
Trimipramine—Nausea—Vinblastine—lung cancer	0.000209	0.00114	CcSEcCtD
Trimipramine—Somnolence—Gemcitabine—lung cancer	0.000209	0.00114	CcSEcCtD
Trimipramine—Convulsion—Paclitaxel—lung cancer	0.000209	0.00114	CcSEcCtD
Trimipramine—Anorexia—Cisplatin—lung cancer	0.000208	0.00114	CcSEcCtD
Trimipramine—Hypertension—Paclitaxel—lung cancer	0.000208	0.00114	CcSEcCtD
Trimipramine—Fatigue—Irinotecan—lung cancer	0.000208	0.00114	CcSEcCtD
Trimipramine—Alopecia—Docetaxel—lung cancer	0.000207	0.00113	CcSEcCtD
Trimipramine—Pruritus—Vinorelbine—lung cancer	0.000207	0.00113	CcSEcCtD
Trimipramine—Discomfort—Etoposide—lung cancer	0.000207	0.00113	CcSEcCtD
Trimipramine—Constipation—Irinotecan—lung cancer	0.000206	0.00113	CcSEcCtD
Trimipramine—Hypotension—Cisplatin—lung cancer	0.000204	0.00112	CcSEcCtD
Trimipramine—Anxiety—Paclitaxel—lung cancer	0.000204	0.00112	CcSEcCtD
Trimipramine—Decreased appetite—Gemcitabine—lung cancer	0.000204	0.00112	CcSEcCtD
Trimipramine—Nausea—Topotecan—lung cancer	0.000203	0.00111	CcSEcCtD
Trimipramine—Discomfort—Paclitaxel—lung cancer	0.000202	0.00111	CcSEcCtD
Trimipramine—Fatigue—Gemcitabine—lung cancer	0.000202	0.00111	CcSEcCtD
Trimipramine—Confusional state—Etoposide—lung cancer	0.000202	0.00111	CcSEcCtD
Trimipramine—Constipation—Gemcitabine—lung cancer	0.000201	0.0011	CcSEcCtD
Trimipramine—Nausea—Erlotinib—lung cancer	0.000201	0.0011	CcSEcCtD
Trimipramine—Pancytopenia—Methotrexate—lung cancer	0.0002	0.0011	CcSEcCtD
Trimipramine—Dry mouth—Paclitaxel—lung cancer	0.0002	0.0011	CcSEcCtD
Trimipramine—Diarrhoea—Vinorelbine—lung cancer	0.0002	0.00109	CcSEcCtD
Trimipramine—Dysgeusia—Docetaxel—lung cancer	0.0002	0.00109	CcSEcCtD
Trimipramine—Ataxia—Doxorubicin—lung cancer	0.000199	0.00109	CcSEcCtD
Trimipramine—Feeling abnormal—Irinotecan—lung cancer	0.000199	0.00109	CcSEcCtD
Trimipramine—Confusional state—Paclitaxel—lung cancer	0.000198	0.00108	CcSEcCtD
Trimipramine—Oedema—Paclitaxel—lung cancer	0.000196	0.00108	CcSEcCtD
Trimipramine—Paraesthesia—Cisplatin—lung cancer	0.000196	0.00108	CcSEcCtD
Trimipramine—Thrombocytopenia—Etoposide—lung cancer	0.000196	0.00107	CcSEcCtD
Trimipramine—Tachycardia—Etoposide—lung cancer	0.000196	0.00107	CcSEcCtD
Trimipramine—ABCB1—trachea—lung cancer	0.000195	0.00891	CbGeAlD
Trimipramine—Erectile dysfunction—Methotrexate—lung cancer	0.000194	0.00106	CcSEcCtD
Trimipramine—Feeling abnormal—Gemcitabine—lung cancer	0.000193	0.00106	CcSEcCtD
Trimipramine—Dizziness—Vinorelbine—lung cancer	0.000193	0.00106	CcSEcCtD
Trimipramine—Thrombocytopenia—Paclitaxel—lung cancer	0.000192	0.00105	CcSEcCtD
Trimipramine—Tachycardia—Paclitaxel—lung cancer	0.000192	0.00105	CcSEcCtD
Trimipramine—Anorexia—Etoposide—lung cancer	0.000191	0.00105	CcSEcCtD
Trimipramine—Body temperature increased—Irinotecan—lung cancer	0.00019	0.00104	CcSEcCtD
Trimipramine—Abdominal pain—Irinotecan—lung cancer	0.00019	0.00104	CcSEcCtD
Trimipramine—Decreased appetite—Cisplatin—lung cancer	0.00019	0.00104	CcSEcCtD
Trimipramine—Drowsiness—Methotrexate—lung cancer	0.000188	0.00103	CcSEcCtD
Trimipramine—Anorexia—Paclitaxel—lung cancer	0.000187	0.00103	CcSEcCtD
Trimipramine—Hypotension—Etoposide—lung cancer	0.000187	0.00103	CcSEcCtD
Trimipramine—Vomiting—Vinorelbine—lung cancer	0.000186	0.00102	CcSEcCtD
Trimipramine—Body temperature increased—Gemcitabine—lung cancer	0.000185	0.00102	CcSEcCtD
Trimipramine—Rash—Vinorelbine—lung cancer	0.000184	0.00101	CcSEcCtD
Trimipramine—Dermatitis—Vinorelbine—lung cancer	0.000184	0.00101	CcSEcCtD
Trimipramine—Hypotension—Paclitaxel—lung cancer	0.000184	0.00101	CcSEcCtD
Trimipramine—Stomatitis—Methotrexate—lung cancer	0.000183	0.001	CcSEcCtD
Trimipramine—Headache—Vinorelbine—lung cancer	0.000183	0.001	CcSEcCtD
Trimipramine—Eosinophilia—Doxorubicin—lung cancer	0.000181	0.000991	CcSEcCtD
Trimipramine—Palpitations—Docetaxel—lung cancer	0.00018	0.000987	CcSEcCtD
Trimipramine—Feeling abnormal—Cisplatin—lung cancer	0.00018	0.000987	CcSEcCtD
Trimipramine—Paraesthesia—Etoposide—lung cancer	0.00018	0.000985	CcSEcCtD
Trimipramine—Somnolence—Etoposide—lung cancer	0.000178	0.000976	CcSEcCtD
Trimipramine—Insomnia—Paclitaxel—lung cancer	0.000178	0.000973	CcSEcCtD
Trimipramine—Convulsion—Docetaxel—lung cancer	0.000177	0.000968	CcSEcCtD
Trimipramine—Paraesthesia—Paclitaxel—lung cancer	0.000176	0.000966	CcSEcCtD
Trimipramine—Hypertension—Docetaxel—lung cancer	0.000176	0.000965	CcSEcCtD
Trimipramine—Desipramine—CYP2A6—lung cancer	0.000176	0.0659	CrCbGaD
Trimipramine—Agranulocytosis—Methotrexate—lung cancer	0.000176	0.000962	CcSEcCtD
Trimipramine—HRH1—lymph node—lung cancer	0.000175	0.008	CbGeAlD
Trimipramine—Somnolence—Paclitaxel—lung cancer	0.000175	0.000957	CcSEcCtD
Trimipramine—Decreased appetite—Etoposide—lung cancer	0.000174	0.000954	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—lung cancer	0.000174	0.00095	CcSEcCtD
Trimipramine—Nausea—Vinorelbine—lung cancer	0.000173	0.00095	CcSEcCtD
Trimipramine—Dyspepsia—Paclitaxel—lung cancer	0.000173	0.000947	CcSEcCtD
Trimipramine—Body temperature increased—Cisplatin—lung cancer	0.000173	0.000947	CcSEcCtD
Trimipramine—Asthenia—Irinotecan—lung cancer	0.000173	0.000947	CcSEcCtD
Trimipramine—Fatigue—Etoposide—lung cancer	0.000173	0.000946	CcSEcCtD
Trimipramine—ADRA2A—lymph node—lung cancer	0.000172	0.00786	CbGeAlD
Trimipramine—Constipation—Etoposide—lung cancer	0.000171	0.000938	CcSEcCtD
Trimipramine—Decreased appetite—Paclitaxel—lung cancer	0.000171	0.000935	CcSEcCtD
Trimipramine—Dry mouth—Docetaxel—lung cancer	0.00017	0.00093	CcSEcCtD
Trimipramine—Fatigue—Paclitaxel—lung cancer	0.000169	0.000928	CcSEcCtD
Trimipramine—Pollakiuria—Doxorubicin—lung cancer	0.000169	0.000925	CcSEcCtD
Trimipramine—Asthenia—Gemcitabine—lung cancer	0.000168	0.000922	CcSEcCtD
Trimipramine—Constipation—Paclitaxel—lung cancer	0.000168	0.00092	CcSEcCtD
Trimipramine—Confusional state—Docetaxel—lung cancer	0.000168	0.00092	CcSEcCtD
Trimipramine—Oedema—Docetaxel—lung cancer	0.000167	0.000912	CcSEcCtD
Trimipramine—Weight increased—Doxorubicin—lung cancer	0.000166	0.000911	CcSEcCtD
Trimipramine—Pruritus—Gemcitabine—lung cancer	0.000166	0.000909	CcSEcCtD
Trimipramine—Feeling abnormal—Etoposide—lung cancer	0.000165	0.000904	CcSEcCtD
Trimipramine—Diarrhoea—Irinotecan—lung cancer	0.000165	0.000903	CcSEcCtD
Trimipramine—Thrombocytopenia—Docetaxel—lung cancer	0.000163	0.000893	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—lung cancer	0.000163	0.000892	CcSEcCtD
Trimipramine—Tachycardia—Docetaxel—lung cancer	0.000163	0.00089	CcSEcCtD
Trimipramine—Feeling abnormal—Paclitaxel—lung cancer	0.000162	0.000887	CcSEcCtD
Trimipramine—Diarrhoea—Gemcitabine—lung cancer	0.000161	0.000879	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—lung cancer	0.00016	0.000875	CcSEcCtD
Trimipramine—Dizziness—Irinotecan—lung cancer	0.000159	0.000872	CcSEcCtD
Trimipramine—Urticaria—Etoposide—lung cancer	0.000159	0.000872	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—lung cancer	0.000159	0.00087	CcSEcCtD
Trimipramine—Jaundice—Doxorubicin—lung cancer	0.000159	0.00087	CcSEcCtD
Trimipramine—Anorexia—Docetaxel—lung cancer	0.000159	0.000869	CcSEcCtD
Trimipramine—Abdominal pain—Etoposide—lung cancer	0.000158	0.000867	CcSEcCtD
Trimipramine—Body temperature increased—Etoposide—lung cancer	0.000158	0.000867	CcSEcCtD
Trimipramine—Tinnitus—Methotrexate—lung cancer	0.000158	0.000863	CcSEcCtD
Trimipramine—Asthenia—Cisplatin—lung cancer	0.000157	0.000859	CcSEcCtD
Trimipramine—Urticaria—Paclitaxel—lung cancer	0.000156	0.000855	CcSEcCtD
Trimipramine—Hypotension—Docetaxel—lung cancer	0.000156	0.000852	CcSEcCtD
Trimipramine—Abdominal pain—Paclitaxel—lung cancer	0.000155	0.000851	CcSEcCtD
Trimipramine—Body temperature increased—Paclitaxel—lung cancer	0.000155	0.000851	CcSEcCtD
Trimipramine—ABCB1—bone marrow—lung cancer	0.000154	0.00706	CbGeAlD
Trimipramine—Epinastine—ABCB1—lung cancer	0.000154	0.0576	CrCbGaD
Trimipramine—Vomiting—Irinotecan—lung cancer	0.000153	0.000839	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—lung cancer	0.000152	0.000833	CcSEcCtD
Trimipramine—Rash—Irinotecan—lung cancer	0.000152	0.000832	CcSEcCtD
Trimipramine—Dermatitis—Irinotecan—lung cancer	0.000152	0.000831	CcSEcCtD
Trimipramine—Nortriptyline—CYP2E1—lung cancer	0.000152	0.0568	CrCbGaD
Trimipramine—Headache—Irinotecan—lung cancer	0.000151	0.000826	CcSEcCtD
Trimipramine—Insomnia—Docetaxel—lung cancer	0.000151	0.000825	CcSEcCtD
Trimipramine—Diarrhoea—Cisplatin—lung cancer	0.00015	0.00082	CcSEcCtD
Trimipramine—Paraesthesia—Docetaxel—lung cancer	0.00015	0.000819	CcSEcCtD
Trimipramine—Alopecia—Methotrexate—lung cancer	0.000149	0.000818	CcSEcCtD
Trimipramine—Vomiting—Gemcitabine—lung cancer	0.000149	0.000817	CcSEcCtD
Trimipramine—Oxcarbazepine—ALB—lung cancer	0.000148	0.0556	CrCbGaD
Trimipramine—Somnolence—Docetaxel—lung cancer	0.000148	0.000811	CcSEcCtD
Trimipramine—Rash—Gemcitabine—lung cancer	0.000148	0.00081	CcSEcCtD
Trimipramine—Dermatitis—Gemcitabine—lung cancer	0.000148	0.00081	CcSEcCtD
Trimipramine—Headache—Gemcitabine—lung cancer	0.000147	0.000805	CcSEcCtD
Trimipramine—Dyspepsia—Docetaxel—lung cancer	0.000147	0.000803	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—lung cancer	0.000146	0.000797	CcSEcCtD
Trimipramine—Decreased appetite—Docetaxel—lung cancer	0.000145	0.000793	CcSEcCtD
Trimipramine—Dysgeusia—Methotrexate—lung cancer	0.000144	0.000789	CcSEcCtD
Trimipramine—Asthenia—Etoposide—lung cancer	0.000144	0.000787	CcSEcCtD
Trimipramine—Fatigue—Docetaxel—lung cancer	0.000144	0.000786	CcSEcCtD
Trimipramine—Nausea—Irinotecan—lung cancer	0.000143	0.000784	CcSEcCtD
Trimipramine—Constipation—Docetaxel—lung cancer	0.000142	0.00078	CcSEcCtD
Trimipramine—Pruritus—Etoposide—lung cancer	0.000142	0.000776	CcSEcCtD
Trimipramine—Asthenia—Paclitaxel—lung cancer	0.000141	0.000772	CcSEcCtD
Trimipramine—ABCB1—lung—lung cancer	0.00014	0.0064	CbGeAlD
Trimipramine—Methotrimeprazine—CYP2E1—lung cancer	0.00014	0.0523	CrCbGaD
Trimipramine—Nausea—Gemcitabine—lung cancer	0.000139	0.000763	CcSEcCtD
Trimipramine—Vomiting—Cisplatin—lung cancer	0.000139	0.000762	CcSEcCtD
Trimipramine—Pruritus—Paclitaxel—lung cancer	0.000139	0.000761	CcSEcCtD
Trimipramine—Vision blurred—Methotrexate—lung cancer	0.000139	0.000759	CcSEcCtD
Trimipramine—Rash—Cisplatin—lung cancer	0.000138	0.000755	CcSEcCtD
Trimipramine—Dermatitis—Cisplatin—lung cancer	0.000138	0.000755	CcSEcCtD
Trimipramine—Feeling abnormal—Docetaxel—lung cancer	0.000137	0.000752	CcSEcCtD
Trimipramine—Diarrhoea—Etoposide—lung cancer	0.000137	0.000751	CcSEcCtD
Trimipramine—Ill-defined disorder—Methotrexate—lung cancer	0.000136	0.000747	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—lung cancer	0.000136	0.000747	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—lung cancer	0.000136	0.000743	CcSEcCtD
Trimipramine—Diarrhoea—Paclitaxel—lung cancer	0.000134	0.000736	CcSEcCtD
Trimipramine—Malaise—Methotrexate—lung cancer	0.000133	0.000726	CcSEcCtD
Trimipramine—Orphenadrine—CYP2E1—lung cancer	0.000133	0.0497	CrCbGaD
Trimipramine—Dizziness—Etoposide—lung cancer	0.000133	0.000726	CcSEcCtD
Trimipramine—Body temperature increased—Docetaxel—lung cancer	0.000132	0.000721	CcSEcCtD
Trimipramine—Abdominal pain—Docetaxel—lung cancer	0.000132	0.000721	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—lung cancer	0.000131	0.000716	CcSEcCtD
Trimipramine—Dizziness—Paclitaxel—lung cancer	0.00013	0.000711	CcSEcCtD
Trimipramine—Nausea—Cisplatin—lung cancer	0.00013	0.000711	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—lung cancer	0.000129	0.000708	CcSEcCtD
Trimipramine—Convulsion—Methotrexate—lung cancer	0.000127	0.000698	CcSEcCtD
Trimipramine—Vomiting—Etoposide—lung cancer	0.000127	0.000698	CcSEcCtD
Trimipramine—Rash—Etoposide—lung cancer	0.000126	0.000692	CcSEcCtD
Trimipramine—Dermatitis—Etoposide—lung cancer	0.000126	0.000691	CcSEcCtD
Trimipramine—Headache—Etoposide—lung cancer	0.000126	0.000687	CcSEcCtD
Trimipramine—Vomiting—Paclitaxel—lung cancer	0.000125	0.000684	CcSEcCtD
Trimipramine—Desipramine—CYP2E1—lung cancer	0.000125	0.0468	CrCbGaD
Trimipramine—Dysgeusia—Doxorubicin—lung cancer	0.000125	0.000683	CcSEcCtD
Trimipramine—Rash—Paclitaxel—lung cancer	0.000124	0.000678	CcSEcCtD
Trimipramine—Dermatitis—Paclitaxel—lung cancer	0.000124	0.000678	CcSEcCtD
Trimipramine—Discomfort—Methotrexate—lung cancer	0.000124	0.000677	CcSEcCtD
Trimipramine—Headache—Paclitaxel—lung cancer	0.000123	0.000674	CcSEcCtD
Trimipramine—Confusional state—Methotrexate—lung cancer	0.000121	0.000663	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—lung cancer	0.00012	0.000657	CcSEcCtD
Trimipramine—Asthenia—Docetaxel—lung cancer	0.000119	0.000654	CcSEcCtD
Trimipramine—Nausea—Etoposide—lung cancer	0.000119	0.000652	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—lung cancer	0.000118	0.000647	CcSEcCtD
Trimipramine—Pruritus—Docetaxel—lung cancer	0.000118	0.000645	CcSEcCtD
Trimipramine—Thrombocytopenia—Methotrexate—lung cancer	0.000118	0.000644	CcSEcCtD
Trimipramine—Agitation—Doxorubicin—lung cancer	0.000117	0.000641	CcSEcCtD
Trimipramine—Nausea—Paclitaxel—lung cancer	0.000117	0.000639	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—lung cancer	0.000115	0.000629	CcSEcCtD
Trimipramine—Anorexia—Methotrexate—lung cancer	0.000114	0.000627	CcSEcCtD
Trimipramine—Diarrhoea—Docetaxel—lung cancer	0.000114	0.000624	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—lung cancer	0.000113	0.000616	CcSEcCtD
Trimipramine—Acepromazine—ALB—lung cancer	0.000112	0.042	CrCbGaD
Trimipramine—Hypotension—Methotrexate—lung cancer	0.000112	0.000614	CcSEcCtD
Trimipramine—Convulsion—Doxorubicin—lung cancer	0.00011	0.000604	CcSEcCtD
Trimipramine—Dizziness—Docetaxel—lung cancer	0.00011	0.000603	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—lung cancer	0.00011	0.000602	CcSEcCtD
Trimipramine—Insomnia—Methotrexate—lung cancer	0.000109	0.000594	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—lung cancer	0.000108	0.000592	CcSEcCtD
Trimipramine—Paraesthesia—Methotrexate—lung cancer	0.000108	0.00059	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—lung cancer	0.000107	0.000587	CcSEcCtD
Trimipramine—Somnolence—Methotrexate—lung cancer	0.000107	0.000584	CcSEcCtD
Trimipramine—Chlorpromazine—CYP2E1—lung cancer	0.000106	0.0399	CrCbGaD
Trimipramine—Dry mouth—Doxorubicin—lung cancer	0.000106	0.000581	CcSEcCtD
Trimipramine—Imipramine—CYP2E1—lung cancer	0.000106	0.0397	CrCbGaD
Trimipramine—Vomiting—Docetaxel—lung cancer	0.000106	0.00058	CcSEcCtD
Trimipramine—Dyspepsia—Methotrexate—lung cancer	0.000106	0.000579	CcSEcCtD
Trimipramine—Amitriptyline—CYP2E1—lung cancer	0.000105	0.0394	CrCbGaD
Trimipramine—Rash—Docetaxel—lung cancer	0.000105	0.000575	CcSEcCtD
Trimipramine—Dermatitis—Docetaxel—lung cancer	0.000105	0.000574	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—lung cancer	0.000105	0.000574	CcSEcCtD
Trimipramine—Decreased appetite—Methotrexate—lung cancer	0.000104	0.000571	CcSEcCtD
Trimipramine—Headache—Docetaxel—lung cancer	0.000104	0.000571	CcSEcCtD
Trimipramine—Oedema—Doxorubicin—lung cancer	0.000104	0.000569	CcSEcCtD
Trimipramine—Fatigue—Methotrexate—lung cancer	0.000103	0.000567	CcSEcCtD
Trimipramine—Thrombocytopenia—Doxorubicin—lung cancer	0.000102	0.000557	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—lung cancer	0.000101	0.000555	CcSEcCtD
Trimipramine—Anorexia—Doxorubicin—lung cancer	9.91e-05	0.000543	CcSEcCtD
Trimipramine—Nausea—Docetaxel—lung cancer	9.89e-05	0.000542	CcSEcCtD
Trimipramine—Feeling abnormal—Methotrexate—lung cancer	9.89e-05	0.000542	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—lung cancer	9.71e-05	0.000532	CcSEcCtD
Trimipramine—Carbamazepine—ABCB1—lung cancer	9.66e-05	0.0362	CrCbGaD
Trimipramine—ABCB1—lymph node—lung cancer	9.56e-05	0.00438	CbGeAlD
Trimipramine—Urticaria—Methotrexate—lung cancer	9.53e-05	0.000522	CcSEcCtD
Trimipramine—Abdominal pain—Methotrexate—lung cancer	9.49e-05	0.00052	CcSEcCtD
Trimipramine—Body temperature increased—Methotrexate—lung cancer	9.49e-05	0.00052	CcSEcCtD
Trimipramine—Insomnia—Doxorubicin—lung cancer	9.4e-05	0.000515	CcSEcCtD
Trimipramine—Paraesthesia—Doxorubicin—lung cancer	9.33e-05	0.000511	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—lung cancer	9.24e-05	0.000506	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—lung cancer	9.15e-05	0.000501	CcSEcCtD
Trimipramine—Decreased appetite—Doxorubicin—lung cancer	9.03e-05	0.000495	CcSEcCtD
Trimipramine—Fatigue—Doxorubicin—lung cancer	8.96e-05	0.000491	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—lung cancer	8.89e-05	0.000487	CcSEcCtD
Trimipramine—Asthenia—Methotrexate—lung cancer	8.61e-05	0.000472	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—lung cancer	8.56e-05	0.000469	CcSEcCtD
Trimipramine—Clomipramine—ALB—lung cancer	8.53e-05	0.032	CrCbGaD
Trimipramine—Pruritus—Methotrexate—lung cancer	8.49e-05	0.000465	CcSEcCtD
Trimipramine—Nortriptyline—ALB—lung cancer	8.33e-05	0.0312	CrCbGaD
Trimipramine—Urticaria—Doxorubicin—lung cancer	8.26e-05	0.000452	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—lung cancer	8.22e-05	0.00045	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—lung cancer	8.22e-05	0.00045	CcSEcCtD
Trimipramine—Diarrhoea—Methotrexate—lung cancer	8.21e-05	0.00045	CcSEcCtD
Trimipramine—Clomipramine—ABCB1—lung cancer	8.14e-05	0.0305	CrCbGaD
Trimipramine—Dizziness—Methotrexate—lung cancer	7.94e-05	0.000435	CcSEcCtD
Trimipramine—Vomiting—Methotrexate—lung cancer	7.63e-05	0.000418	CcSEcCtD
Trimipramine—Rash—Methotrexate—lung cancer	7.57e-05	0.000414	CcSEcCtD
Trimipramine—Dermatitis—Methotrexate—lung cancer	7.56e-05	0.000414	CcSEcCtD
Trimipramine—Headache—Methotrexate—lung cancer	7.52e-05	0.000412	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—lung cancer	7.46e-05	0.000408	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—lung cancer	7.35e-05	0.000403	CcSEcCtD
Trimipramine—Promethazine—ABCB1—lung cancer	7.21e-05	0.027	CrCbGaD
Trimipramine—Doxepin—ABCB1—lung cancer	7.13e-05	0.0267	CrCbGaD
Trimipramine—Nausea—Methotrexate—lung cancer	7.13e-05	0.00039	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—lung cancer	7.11e-05	0.000389	CcSEcCtD
Trimipramine—Methadone—ABCB1—lung cancer	7.1e-05	0.0266	CrCbGaD
Trimipramine—Dizziness—Doxorubicin—lung cancer	6.87e-05	0.000376	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—lung cancer	6.61e-05	0.000362	CcSEcCtD
Trimipramine—Rash—Doxorubicin—lung cancer	6.55e-05	0.000359	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—lung cancer	6.55e-05	0.000359	CcSEcCtD
Trimipramine—Desipramine—ABCB1—lung cancer	6.55e-05	0.0245	CrCbGaD
Trimipramine—Headache—Doxorubicin—lung cancer	6.51e-05	0.000357	CcSEcCtD
Trimipramine—Nausea—Doxorubicin—lung cancer	6.17e-05	0.000338	CcSEcCtD
Trimipramine—Chlorpromazine—ALB—lung cancer	5.85e-05	0.0219	CrCbGaD
Trimipramine—Amitriptyline—ALB—lung cancer	5.78e-05	0.0217	CrCbGaD
Trimipramine—Chlorpromazine—ABCB1—lung cancer	5.58e-05	0.0209	CrCbGaD
Trimipramine—Imipramine—ABCB1—lung cancer	5.55e-05	0.0208	CrCbGaD
Trimipramine—Amitriptyline—ABCB1—lung cancer	5.52e-05	0.0207	CrCbGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	4.08e-06	3.3e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTEN—lung cancer	4.08e-06	3.3e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	4.07e-06	3.29e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—lung cancer	4.06e-06	3.28e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MDM2—lung cancer	4.06e-06	3.28e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	4.06e-06	3.28e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—lung cancer	4.06e-06	3.28e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—POMC—lung cancer	4.06e-06	3.28e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—lung cancer	4.05e-06	3.27e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CREBBP—lung cancer	4.05e-06	3.27e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RAF1—lung cancer	4.04e-06	3.27e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	4.03e-06	3.26e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—lung cancer	4.03e-06	3.26e-05	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—lung cancer	4.03e-06	3.26e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SRC—lung cancer	4.03e-06	3.25e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—lung cancer	4.02e-06	3.25e-05	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—lung cancer	4.02e-06	3.25e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CG—lung cancer	4.02e-06	3.25e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NRAS—lung cancer	4.01e-06	3.24e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SRC—lung cancer	4.01e-06	3.24e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	4e-06	3.23e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—lung cancer	3.99e-06	3.23e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—lung cancer	3.99e-06	3.22e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—lung cancer	3.98e-06	3.22e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CG—lung cancer	3.98e-06	3.22e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—lung cancer	3.98e-06	3.21e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—lung cancer	3.97e-06	3.21e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—lung cancer	3.97e-06	3.2e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—lung cancer	3.96e-06	3.2e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CREBBP—lung cancer	3.95e-06	3.19e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—lung cancer	3.95e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MTOR—lung cancer	3.95e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	3.95e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	3.95e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EP300—lung cancer	3.94e-06	3.19e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—JUN—lung cancer	3.94e-06	3.18e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—lung cancer	3.92e-06	3.17e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—lung cancer	3.91e-06	3.16e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—lung cancer	3.9e-06	3.15e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—lung cancer	3.9e-06	3.15e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—EP300—lung cancer	3.89e-06	3.14e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—lung cancer	3.89e-06	3.14e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—lung cancer	3.88e-06	3.14e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—lung cancer	3.88e-06	3.14e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—JUN—lung cancer	3.88e-06	3.13e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—lung cancer	3.88e-06	3.13e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NRAS—lung cancer	3.87e-06	3.13e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—JUN—lung cancer	3.87e-06	3.13e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—lung cancer	3.86e-06	3.12e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NRAS—lung cancer	3.85e-06	3.11e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—lung cancer	3.85e-06	3.11e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK3—lung cancer	3.84e-06	3.11e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CD—lung cancer	3.84e-06	3.1e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SRC—lung cancer	3.83e-06	3.1e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—lung cancer	3.83e-06	3.1e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—POMC—lung cancer	3.82e-06	3.09e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1A—lung cancer	3.82e-06	3.09e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—lung cancer	3.81e-06	3.08e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—lung cancer	3.8e-06	3.07e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—lung cancer	3.8e-06	3.07e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—JUN—lung cancer	3.8e-06	3.07e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	3.79e-06	3.07e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—POMC—lung cancer	3.79e-06	3.06e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—lung cancer	3.79e-06	3.06e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—lung cancer	3.77e-06	3.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	3.77e-06	3.05e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—lung cancer	3.76e-06	3.04e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	3.76e-06	3.04e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1A—lung cancer	3.75e-06	3.03e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—lung cancer	3.75e-06	3.03e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CD—lung cancer	3.75e-06	3.03e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CAT—lung cancer	3.74e-06	3.03e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—lung cancer	3.74e-06	3.02e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—lung cancer	3.74e-06	3.02e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	3.73e-06	3.02e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CREBBP—lung cancer	3.72e-06	3.01e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—lung cancer	3.72e-06	3e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK3—lung cancer	3.71e-06	3e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—lung cancer	3.7e-06	2.99e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—lung cancer	3.7e-06	2.99e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—lung cancer	3.69e-06	2.98e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CREBBP—lung cancer	3.69e-06	2.98e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK3—lung cancer	3.69e-06	2.98e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NRAS—lung cancer	3.69e-06	2.98e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	3.68e-06	2.97e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—lung cancer	3.67e-06	2.97e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	3.67e-06	2.96e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—lung cancer	3.66e-06	2.96e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—lung cancer	3.66e-06	2.95e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—lung cancer	3.65e-06	2.95e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCB1—lung cancer	3.64e-06	2.94e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—lung cancer	3.64e-06	2.94e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EP300—lung cancer	3.63e-06	2.94e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—lung cancer	3.63e-06	2.93e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—lung cancer	3.63e-06	2.93e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—lung cancer	3.61e-06	2.92e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—lung cancer	3.61e-06	2.92e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—lung cancer	3.59e-06	2.9e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	3.58e-06	2.9e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TYMS—lung cancer	3.58e-06	2.89e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EP300—lung cancer	3.58e-06	2.89e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EP300—lung cancer	3.57e-06	2.88e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—lung cancer	3.54e-06	2.86e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—lung cancer	3.53e-06	2.86e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SRC—lung cancer	3.53e-06	2.86e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	3.53e-06	2.85e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CD—lung cancer	3.53e-06	2.85e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—lung cancer	3.53e-06	2.85e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—JUN—lung cancer	3.53e-06	2.85e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—lung cancer	3.51e-06	2.84e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EP300—lung cancer	3.5e-06	2.83e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CD—lung cancer	3.5e-06	2.83e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—lung cancer	3.48e-06	2.82e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SRC—lung cancer	3.48e-06	2.81e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SRC—lung cancer	3.47e-06	2.8e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—lung cancer	3.45e-06	2.79e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—lung cancer	3.45e-06	2.79e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—lung cancer	3.44e-06	2.78e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—lung cancer	3.44e-06	2.78e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—lung cancer	3.43e-06	2.77e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	3.42e-06	2.76e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—lung cancer	3.41e-06	2.76e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—lung cancer	3.41e-06	2.75e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SRC—lung cancer	3.41e-06	2.75e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NRAS—lung cancer	3.4e-06	2.75e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—lung cancer	3.39e-06	2.74e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—lung cancer	3.38e-06	2.73e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—lung cancer	3.36e-06	2.72e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—lung cancer	3.35e-06	2.71e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—lung cancer	3.35e-06	2.71e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP1A1—lung cancer	3.35e-06	2.71e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—lung cancer	3.35e-06	2.7e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NRAS—lung cancer	3.35e-06	2.7e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CB—lung cancer	3.35e-06	2.7e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NRAS—lung cancer	3.34e-06	2.7e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—lung cancer	3.33e-06	2.69e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	3.33e-06	2.69e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ERCC2—lung cancer	3.32e-06	2.69e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	3.32e-06	2.68e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—lung cancer	3.32e-06	2.68e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—lung cancer	3.31e-06	2.68e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—lung cancer	3.28e-06	2.65e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NRAS—lung cancer	3.28e-06	2.65e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CB—lung cancer	3.27e-06	2.64e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK3—lung cancer	3.26e-06	2.63e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EP300—lung cancer	3.25e-06	2.63e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—lung cancer	3.24e-06	2.61e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK3—lung cancer	3.2e-06	2.59e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK3—lung cancer	3.2e-06	2.58e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—lung cancer	3.17e-06	2.57e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	3.17e-06	2.56e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—lung cancer	3.17e-06	2.56e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SRC—lung cancer	3.16e-06	2.56e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	3.14e-06	2.54e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—lung cancer	3.12e-06	2.52e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—lung cancer	3.11e-06	2.51e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—lung cancer	3.1e-06	2.5e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	3.08e-06	2.49e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CB—lung cancer	3.08e-06	2.49e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—lung cancer	3.07e-06	2.48e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	3.06e-06	2.47e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—lung cancer	3.05e-06	2.47e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—lung cancer	3.05e-06	2.47e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CB—lung cancer	3.05e-06	2.47e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—lung cancer	3.05e-06	2.46e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—lung cancer	3.05e-06	2.46e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	3.05e-06	2.46e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NRAS—lung cancer	3.04e-06	2.46e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—lung cancer	3.04e-06	2.46e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—lung cancer	3.02e-06	2.44e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—lung cancer	2.98e-06	2.41e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—lung cancer	2.96e-06	2.39e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—lung cancer	2.95e-06	2.38e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—lung cancer	2.94e-06	2.37e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—lung cancer	2.93e-06	2.37e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	2.92e-06	2.36e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	2.92e-06	2.36e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—lung cancer	2.89e-06	2.34e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—lung cancer	2.88e-06	2.33e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—lung cancer	2.88e-06	2.33e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOA1—lung cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—lung cancer	2.87e-06	2.32e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—lung cancer	2.84e-06	2.29e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—lung cancer	2.83e-06	2.29e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—lung cancer	2.82e-06	2.28e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—lung cancer	2.82e-06	2.28e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—lung cancer	2.82e-06	2.28e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—lung cancer	2.82e-06	2.28e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—lung cancer	2.81e-06	2.27e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—lung cancer	2.77e-06	2.24e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—EP300—lung cancer	2.76e-06	2.23e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—lung cancer	2.71e-06	2.19e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—lung cancer	2.7e-06	2.18e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—lung cancer	2.7e-06	2.18e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—EP300—lung cancer	2.69e-06	2.17e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.69e-06	2.17e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—lung cancer	2.66e-06	2.15e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.65e-06	2.14e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—lung cancer	2.64e-06	2.13e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—lung cancer	2.64e-06	2.13e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CG—lung cancer	2.63e-06	2.12e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.62e-06	2.12e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—lung cancer	2.6e-06	2.1e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—lung cancer	2.59e-06	2.09e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	2.59e-06	2.09e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—lung cancer	2.58e-06	2.09e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—lung cancer	2.56e-06	2.07e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—lung cancer	2.55e-06	2.06e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—EP300—lung cancer	2.54e-06	2.05e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—EP300—lung cancer	2.51e-06	2.03e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—lung cancer	2.51e-06	2.03e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—lung cancer	2.5e-06	2.02e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—POMC—lung cancer	2.5e-06	2.02e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—lung cancer	2.49e-06	2.01e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—lung cancer	2.49e-06	2.01e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—lung cancer	2.45e-06	1.98e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—lung cancer	2.44e-06	1.97e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CREBBP—lung cancer	2.43e-06	1.97e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	2.41e-06	1.95e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—lung cancer	2.4e-06	1.94e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—lung cancer	2.38e-06	1.93e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—lung cancer	2.38e-06	1.92e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—lung cancer	2.35e-06	1.9e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—lung cancer	2.34e-06	1.89e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—lung cancer	2.34e-06	1.89e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—lung cancer	2.33e-06	1.88e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.31e-06	1.87e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—lung cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—lung cancer	2.28e-06	1.84e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—lung cancer	2.23e-06	1.8e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—lung cancer	2.2e-06	1.78e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—lung cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—lung cancer	2.16e-06	1.74e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—lung cancer	2.13e-06	1.72e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—lung cancer	2.12e-06	1.71e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—lung cancer	2.04e-06	1.65e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.01e-06	1.63e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—lung cancer	1.99e-06	1.61e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—lung cancer	1.99e-06	1.61e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.97e-06	1.59e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.88e-06	1.52e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—lung cancer	1.86e-06	1.5e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—lung cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—lung cancer	1.67e-06	1.35e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—EP300—lung cancer	1.66e-06	1.34e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—lung cancer	1.63e-06	1.31e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—lung cancer	1.53e-06	1.24e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—lung cancer	1.52e-06	1.23e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.23e-06	9.91e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—lung cancer	1e-06	8.1e-06	CbGpPWpGaD
